Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1102

1.

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.

Chen YT, Kitabayashi N, Zhou XK, Fahey TJ 3rd, Scognamiglio T.

Mod Pathol. 2008 Sep;21(9):1139-46. doi: 10.1038/modpathol.2008.105. Epub 2008 Jun 27.

2.

MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.

Vriens MR, Weng J, Suh I, Huynh N, Guerrero MA, Shen WT, Duh QY, Clark OH, Kebebew E.

Cancer. 2012 Jul 1;118(13):3426-32. doi: 10.1002/cncr.26587. Epub 2011 Oct 17.

3.

A molecular expression signature distinguishing follicular lesions in thyroid carcinoma using preamplification RT-PCR in archival samples.

Denning KM, Smyth PC, Cahill SF, Finn SP, Conlon E, Li J, Flavin RJ, Aherne ST, Guenther SM, Ferlinz A, O'Leary JJ, Sheils OM.

Mod Pathol. 2007 Oct;20(10):1095-102. Epub 2007 Jul 27.

4.

Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.

Kebebew E, Peng M, Reiff E, Duh QY, Clark OH, McMillan A.

Surgery. 2005 Dec;138(6):1102-9; discussion 1109-10.

PMID:
16360397
5.

Human telomerase reverse transcriptase expression in Diff-Quik-stained FNA samples from thyroid nodules.

Siddiqui MT, Greene KL, Clark DP, Xydas S, Udelsman R, Smallridge RC, Zeiger MA, Saji M.

Diagn Mol Pathol. 2001 Jun;10(2):123-9.

PMID:
11385322
6.

A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.

Keutgen XM, Filicori F, Crowley MJ, Wang Y, Scognamiglio T, Hoda R, Buitrago D, Cooper D, Zeiger MA, Zarnegar R, Elemento O, Fahey TJ 3rd.

Clin Cancer Res. 2012 Apr 1;18(7):2032-8. doi: 10.1158/1078-0432.CCR-11-2487. Epub 2012 Feb 20.

7.

Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?

Lassalle S, Hofman V, Ilie M, Bonnetaud C, Puisségur MP, Brest P, Loubatier C, Guevara N, Bordone O, Cardinaud B, Lebrigand K, Rios G, Santini J, Franc B, Mari B, Al Ghuzlan A, Vielh P, Barbry P, Hofman P.

Endocr Relat Cancer. 2011 Sep 13;18(5):579-94. doi: 10.1530/ERC-10-0283. Print 2011 Oct.

8.

Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.

Liou MJ, Chan EC, Lin JD, Liu FH, Chao TC.

Cancer Lett. 2003 Mar 10;191(2):223-7.

PMID:
12618337
9.

A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression.

Rosen J, He M, Umbricht C, Alexander HR, Dackiw AP, Zeiger MA, Libutti SK.

Surgery. 2005 Dec;138(6):1050-6; discussion 1056-7.

PMID:
16360390
10.

Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.

Dettmer M, Perren A, Moch H, Komminoth P, Nikiforov YE, Nikiforova MN.

Thyroid. 2013 Nov;23(11):1383-9. doi: 10.1089/thy.2012.0632. Epub 2013 Sep 19.

11.

MicroRNA deregulation in human thyroid papillary carcinomas.

Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, Chiappetta G, Liu CG, Santoro M, Negrini M, Croce CM, Fusco A.

Endocr Relat Cancer. 2006 Jun;13(2):497-508.

12.

Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours.

Sheu SY, Grabellus F, Schwertheim S, Worm K, Broecker-Preuss M, Schmid KW.

Br J Cancer. 2010 Jan 19;102(2):376-82. doi: 10.1038/sj.bjc.6605493. Epub 2009 Dec 22.

13.

Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma.

Schwertheim S, Sheu SY, Worm K, Grabellus F, Schmid KW.

Horm Metab Res. 2009 Jun;41(6):475-81. doi: 10.1055/s-0029-1215593. Epub 2009 Apr 15.

PMID:
19370508
14.

Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.

Mitomo S, Maesawa C, Ogasawara S, Iwaya T, Shibazaki M, Yashima-Abo A, Kotani K, Oikawa H, Sakurai E, Izutsu N, Kato K, Komatsu H, Ikeda K, Wakabayashi G, Masuda T.

Cancer Sci. 2008 Feb;99(2):280-6. doi: 10.1111/j.1349-7006.2007.00666.x. Epub 2008 Jan 14.

15.

CD57 (Leu-7) expression is helpful in diagnosis of the follicular variant of papillary thyroid carcinoma.

Khan A, Baker SP, Patwardhan NA, Pullman JM.

Virchows Arch. 1998 May;432(5):427-32.

PMID:
9645441
16.

miRNA expression profiling of 'noninvasive follicular thyroid neoplasms with papillary-like nuclear features' compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas.

Borrelli N, Denaro M, Ugolini C, Poma AM, Miccoli M, Vitti P, Miccoli P, Basolo F.

Mod Pathol. 2017 Jan;30(1):39-51. doi: 10.1038/modpathol.2016.157. Epub 2016 Sep 2.

17.

Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.

Chiappetta G, Tallini G, De Biasio MC, Manfioletti G, Martinez-Tello FJ, Pentimalli F, de Nigris F, Mastro A, Botti G, Fedele M, Berger N, Santoro M, Giancotti V, Fusco A.

Cancer Res. 1998 Sep 15;58(18):4193-8.

18.

Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.

Fulci V, Colombo T, Chiaretti S, Messina M, Citarella F, Tavolaro S, Guarini A, Foà R, Macino G.

Genes Chromosomes Cancer. 2009 Dec;48(12):1069-82. doi: 10.1002/gcc.20709.

PMID:
19760605
19.

In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.

Guo Z, Hardin H, Montemayor-Garcia C, Asioli S, Righi A, Maletta F, Sapino A, Lloyd RV.

Endocr Pathol. 2015 May;26(2):157-63. doi: 10.1007/s12022-015-9363-x.

PMID:
25771986
20.

Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.

Patnaik SK, Kannisto E, Knudsen S, Yendamuri S.

Cancer Res. 2010 Jan 1;70(1):36-45. doi: 10.1158/0008-5472.CAN-09-3153. Epub 2009 Dec 22.

Supplemental Content

Support Center